SR-9009 (Stenabolic) has been developed by Scripps Research Institute under the leadership of professor Thomas Burris.Initial findings were published in the journal Nature Medicine in 2012, with studies showing that Stenabolic significantly increases exercise endurance in animal models.The compound affects the core biological clock, synchronizing the body’s circadian rhythm with the 24-hour cycle of day and night.
SR-9009 is a synthetic Rev-Erb ligand, which is taken orally. This is a very unique compound. By stimulating the Rev-Erb protein, SR-9009 has the ability to greatly influence a lot of regulatory mechanisms in the human body. For instance, it can affect the circadian rhythms, lipid and glucose metabolism, fat-storing cells, as well as macrophages. Hence, Stenabolic will allow the user to lose fat and drastically increase endurance, both of which are very desirable effects for an athlete.
The user will experience a lot of positive effects, such as increased fat loss, enhanced endurance, and many other health benefits. Interestingly, it is one of the newest advances in pharmacology, but it is already getting more and more popular among athletes all over the world.
As a consequence of the increased number of mitochondria in the muscles, the user will notice a drastic improvement in endurance and muscle strength. In fact, the mice used in studies could run 50% more when they were administered with SR-9009, both in terms of distance and time. Obese rats receiving multiple doses of SR-9009 lost 60% more weight than placebo-treated rats without any change in diet or exercise. This is possible due to the fact that these mitochondria are precisely the ones generating energy in the body. Besides, thanks to the increase in a number of macrophages, defective mitochondria are removed from the muscles and replaced with new ones.
Nicknamed “Cardio in a pill”, it can be the perfect complement.